Abstract:It is generally agreed that the liver is a key organ in the maintenance of cholesterol homeostasis. Although species variations do exist (1), there is no question that the liver makes a very significant contribution to whole body cholesterol synthesis (2). Indeed, recent studies in the rat suggest that the liver may be responsible for the synthesis of greater than 80% of newly synthesized cholesterol in the body (3). It is also well established that the liver is a major site of uptake of cholesterol from lipoprotein particles (1). The acquisition of cholesterol from lipoprotein particles is a process which occurs via both receptor-independent and receptor-dependent pathways (1). The latter pathway is considered to be more important not only from a quantitative standpoint (1) but also because of the fact that the activity of certain receptors is regulated by the hepatic demand for cholesterol (4). These observations, combined with the fact that the liver is the major site (if not the only site) of synthesis of bile acid, the chief catabolic product of cholesterol (5), suggest that the key hepatic enzymes involved in cholesterol metabolism must be very carefully regulated in order to maintain cholesterol homeostasis. Hepatic cholesterol 7α-hydroxylase (CH-7A, EC 1.14.13.7) and β-hydroxy-β-methyl-glutaryl coenzyme A reductase (HMGCoA reductase, EC 1.1.1.34) are the two key enzymes of cholesterol metabolism in the liver (2, 6). HMGCoA reductase is the rate-limiting enzyme in the biosynthesis of cholesterol (2), while CH-7A is considered to be the rate-limiting enzyme in the biosynthesis of bile acids from cholesterol (6). Since cholesterol is the precursor for bile acid biosynthesis, changes in the rate of synthesis of bile acids, in general, affect the rate of biosynthesis of cholesterol (6). Thus, the two enzymes are regulated in a coordinated manner (6).

Regulation of Cholesterol and Fatty Acid Synthesis

Sterol regulatory element binding proteins and lipid metabolism

Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.

SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond

N-SREBP2 Provides a Mechanism for Dynamic Control of Cellular Cholesterol Homeostasis

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies

Mechanisms of cholesterol and sterol regulatory element binding protein regulation of the sterol 12α-hydroxylase gene (CYP8B1)☆

Mechanisms of Negative Feedback Regulation of Cholesterol Biosynthesis

Sterol regulatory element binding protein and nonalcoholic fatty liver disease

Mechanisms of cholesterol and sterol regulatory element binding protein regulation of the sterol 12alpha-hydroxylase gene (CYP8B1).

Regulation of fatty acid and cholesterol synthesis: co-operation or competition?

Sterol-responsive Element-binding Protein (SREBP) 2 Down-regulates ATP-binding Cassette Transporter A1 in Vascular Endothelial Cells: A NOVEL ROLE OF SREBP IN REGULATING CHOLESTEROL METABOLISM

Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6

Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake.

SREBP： a Novel Therapeutic Target

Advanced Research of SREBP-1c Transcriptional Regulation in Fatty Liver Formation

Rhomboid protease RHBDL4/RHBDD1 cleaves SREBP-1c at endoplasmic reticulum monitoring and regulating fatty acids

SCAP and Regulation Mechanism of Cholesterol Level

Feeding-Induced Regulation of Cholesterol Metabolism: A Unified Proposal

The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors

Research Progress of Mechanism of Action of Proteins in Cholesterol Metabolism of Sterol Regulatory Element Binding